Circulatory kinetics of intravenously injected 238Pu(IV) citrate and 14C-CaNa3-DTPA in mice: Comparison with rat, dog, and reference man

Health Physics

Volumn 72, Issue 2, 1997, Pages 222-235

  Durbin, Patricia W ^b   Kullgren, Birgitta ^b   Schmidt, Charles T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

biokinetics; blood; Ca DTPA; plutonium

Indexed keywords

CARBON 14; CITRIC ACID; INULIN; PENTETATE CALCIUM TRISODIUM; PLUTONIUM 238; TRANSFERRIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHELATION; CONTROLLED STUDY; DRUG DISPOSITION; DRUG EXCRETION; DRUG UPTAKE; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; MOUSE; NONHUMAN; PLASMA CLEARANCE; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; REFERENCE VALUE; URINARY EXCRETION;

EID: 0031029563     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004032-199702000-00005     Document Type: Article

References (39)

1. Altman, P. L.; Dittmer, D. S. Renal function tests: Vertebrates. In: Metabolism. Bethesda, MD: Federation of American Societies for Experimental Biology; 1968: 562-572.
2. Bhattacharyya, M. H.; Peterson, D. P. Action of DTPA on hepatic plutonium. III. Evidence for a direct chelation mechanism of DTPA-induced excretion of monomeric plutonium into rat bile. Radiat. Res. 80:108-115; 1979.
3. Bohne, F.; Harmuth-Hoene, A.-E.; Kurzinger, K.; Havlicek, F. Metabolismus und Toxizität therapeutischer Chelatbildner. 5. Mitteilung: Der physiologische Verdunnungsraum des EDTA und DTPA. Strahlentherapie 136:609-616; 1968 (in German).
4. Brody, S. Bioenergetics and growth. New-York, NY: Reinhold Publishing Co.; 1945.
5. Coxson, P. Pharmacokinetics. In: Webster, J. G., ed. Encyclopedia of medical devices and instrumentation. Vol. 4. New York: John Wiley and Sons; 1988:2254-2265.
6. Durbin, P. W. Metabolism and biological effects of the transplutonium elements. In: Hodge, H. C.; Stannard, J. N.; Hursh, J. B., eds. Uranium, plutonium, transplutonic elements. Handbuch Exptl. Pharamacol. 36:739-896; 1973.
7. Durbin, P. W.; Schmidt, C. T. Predicting the kinetics of chelating agents in man from animal data. Health Phys. 57(Suppl. 1):165-174; 1989.
8. Durbin, P. W.; Horovitz, M. W.; Close, E. R. Plutonium deposition kinetics in the rat. Health Phys. 22:731-741; 1972.
9. 238Pu(IV) from mice by sulfonated tetrameric catechoylamides. Radiat. Res. 81:170-187; 1980.
10. 238Pu elimination from mice by poly(catechoylamide) ligands. Radiat. Res. 99:85-105; 1984.
11. 238Pu(IV) from mice by poly-catecholate, -hydroxamate or -hydroxypyridinonate ligands. Radiat. Prot. Dosim. 26:351-358; 1989.
12. Durbin, P. W.; Jeung, N.; Kullgren, B.; Clemons, G. K. Gross composition and plasma and extracellular water volumes of tissues of a reference mouse. Health Phys. 63:427-442; 1992.
13. Durbin, P. W.; Kullgren, B.; Xu, J.; Raymond, K. N. In vivo chelation of Am(III), Pu(IV), Np(V) and U(VI) in mice by TREN-(Me-3,2-HOPO). Radiat. Prot. Dosim. 53:305-309; 1994.
14. Durbin, P. W.; Kullgren, B.; Jeung, N.; Xu, J.; Rodgers, S. J.; Raymond, K. N. Octadentate catecholamide ligands for Pu(IV) based on linear or preorganized molecular back-bones. Human Exptl. Toxicol. 15:352-360; 1996.
15. 131I) volumes of rats determined by liquid nitrogen freezing. Circ. Res. 4:419-424; 1956.
16. Foreman, H. The pharmacology of some useful chelating agents. In: Seven, M. J. and Johnson, L. A., eds. Metal-binding in medicine. Philadelphia, PA: J. B. Lippincott Co.; 1959; 82-94.
17. Harris, W. R.; Carrano, C. J.; Pecoraro, V. L.; Raymond, K. N. Complexationof thorium by transferrin: Structure-function implications. J. Am. Chem. Soc. 103:2231-2237; 1981.
18. International Commission on Radiological Protection. Report of the task group on Reference man. Oxford, England: Pergammon Press; ICRP publication 23; 1975.
19. Lloyd, R. D.; Mays, C. W.; Taylor, G. N.; Atherton, D. R. Americium-241 studies in beagles. Health Phys. 18:149-156; 1970.
20. Lloyd, R. D.; Bruenger, F. L.; Mays, C. W.; Atherton, D. R.; Jones, C. W.; Taylor, G. N.; Stevens, W.; Durbin, P. W.; Jeung, N. J.; Jones, E. S.; Kappel, M. J.; Raymond, K. N.; Weitl, F. L. Removal of plutonium and Am from beagles and mice by 3,4,3-LICAM(C) or 3,4,3-LICAM(S). Radiat. Res. 99:106-128; 1984.
21. Mack, C. Essentials of statistics for scientists and technologists. New York, NY: Plenum Press; 1967.
22. Mitruka, B. M.; Rawnsley, H. W. Clinical biochemical and hematological reference values in normal experimental animals. New York: Manon Publishing; 1977.
23. Parkinson, J. E.; Dougherty, J. H. Effect of internal emitters on red cell and plasma volumes of beagle dogs. Proc. Soc. Exptl. Biol. Med. 97:722-725; 1958.
24. Popplewell, D. S.; Boocock, G. Distribution of some actinides in blood serum proteins. In: Kornberg, H. A.; Horwood, W. D., eds., Diagnosis and treatment of deposited radionuclides. Amsterdam, The Netherlands: Excerpta Medica Foundation; 1967:45-55.
25. Pierson, R. N., Jr.; Price, D. C.; Wang, J.; Jain, R. K. Extracellular water measurements: Organ tracer kinetics of bromide and sucrose in rats and man. Am. J. Physiol. 235:F254-F264; 1978.
26. Popplewell, D. S.; Stradling, G. N.; Ham, G. J. The chemical form of plutonium in urine. Radiat. Res. 62:513-519; 1975.
27. Schubert, J.; Finkel, M.; White, M.; Hirsch, G. M. Plutonium and yttrium content of the blood, liver, and skeleton of the rat at different times after intravenous administration. J. Biol. Chem. 182:635-642; 1950.
28. Simpson, M. E.; Asling, C. W.; Evans, H. M. Some endocrine influences on skeletal growth and differentiation. Yale J. Biol. Med. 23:1-27; 1950.
29. Smith, H. W. The kidney. New York, NY: Oxford University Press; 1951.
30. 14C-DTPA in human volunteers after inhalation or intravenous injection. Health Phys. 44:45-52; 1983.
31. 14C]DTPA in rats and beagles. Radiat. Res. 75:397-409; 1978.
32. 233U in the beagle. Radiat. Res. 83:109-126; 1980.
33. 239 in adult beagle dogs. Radiat. Res. 10:130-147; 1959.
34. Stover, B. J.; Bruenger, F. W.; Stevens, W. The reaction of Pu(IV) with the iron transport system in human blood serum. Radiat. Res. 33:381-394; 1968.
35. Stradling, T. N.; Gray, S. A.; Moody, J. C.; Hodgson, A.; Raymond, K. N.; Durbin, P. W.; Rodgers, S. J.; White, D. L.; Turowski, P. N. The efficacy of DFO-HOPO, DTPA-DX, and DTPA for enhancing the excretion of plutonium and americium from the rat. Int. J. Radiat. Biol. 59:1269-1277; 1991.
36. Talbot, R. J.; Newton, D.; Warner, A. J. Metabolism of injected plutonium in two healthy men. Health Phys. 65:41-46; 1993.
37. Taylor, D. M.; Sowby, F. D.; Kember, N. F. The metabolism of americium and plutonium in the rat. Phys. Med. Biol. 6:73-86; 1961.
38. White, D. L.; Durbin, P. W.; Jeung, N.; Raymond, K. N. Synthesis and initial biological testing of polydentate oxohydroxypyridinecarboxylate ligands. J. Med. Chem. 31:11-18; 1988.
39. Xu, J.; Kullgren, B.; Durbin, P. W.; Raymond, K. N. Synthesis and initial evaluation of multidentate 4-carbamoyl-3-hydroxy-1-methyl-2(1H)-pyridinone ligands for in vivo Pu(IV) chelation. J. Med. Chem. 38:2606-2614; 1995.